vs
CLEVELAND-CLIFFS INC.（CLF）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是CLEVELAND-CLIFFS INC.的1.7倍（$7.2B vs $4.3B），Stryker Corporation净利率更高（11.8% vs -5.6%，领先17.4%），Stryker Corporation同比增速更快（11.4% vs -0.3%），Stryker Corporation自由现金流更多（$1.9B vs $-153.0M），过去两年Stryker Corporation的营收复合增速更高（16.9% vs -8.9%）
克利夫兰-克利夫斯公司是总部位于美国俄亥俄州克利夫兰的钢铁制造商，业务覆盖铁矿石开采、选矿、造球及钢铁冶炼，包含冲压与模具制造，是美国第二大钢铁生产商、北美最大扁钢生产商，位列财富500强第221位、福布斯全球2000强第1511位。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
CLF vs SYK — 直观对比
营收规模更大
SYK
是对方的1.7倍
$4.3B
营收增速更快
SYK
高出11.7%
-0.3%
净利率更高
SYK
高出17.4%
-5.6%
自由现金流更多
SYK
多$2.0B
$-153.0M
两年增速更快
SYK
近两年复合增速
-8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.3B | $7.2B |
| 净利润 | $-241.0M | $849.0M |
| 毛利率 | -5.0% | 64.5% |
| 营业利润率 | -7.9% | 25.2% |
| 净利率 | -5.6% | 11.8% |
| 营收同比 | -0.3% | 11.4% |
| 净利润同比 | 46.1% | 55.5% |
| 每股收益（稀释后） | — | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLFSYK
| Q4 25 | $4.3B | $7.2B | ||
| Q3 25 | $4.7B | $6.1B | ||
| Q2 25 | $4.9B | $6.0B | ||
| Q1 25 | $4.6B | $5.9B | ||
| Q4 24 | $4.3B | $6.4B | ||
| Q3 24 | $4.6B | $5.5B | ||
| Q2 24 | $5.1B | $5.4B | ||
| Q1 24 | $5.2B | $5.2B |
净利润CLFSYK
| Q4 25 | $-241.0M | $849.0M | ||
| Q3 25 | $-251.0M | $859.0M | ||
| Q2 25 | $-470.0M | $884.0M | ||
| Q1 25 | $-483.0M | $654.0M | ||
| Q4 24 | $-447.0M | $546.0M | ||
| Q3 24 | $-242.0M | $834.0M | ||
| Q2 24 | $2.0M | $825.0M | ||
| Q1 24 | $-67.0M | $788.0M |
毛利率CLFSYK
| Q4 25 | -5.0% | 64.5% | ||
| Q3 25 | -1.0% | 63.6% | ||
| Q2 25 | -4.2% | 63.8% | ||
| Q1 25 | -8.4% | 63.8% | ||
| Q4 24 | -6.3% | 64.9% | ||
| Q3 24 | -2.3% | 64.0% | ||
| Q2 24 | 3.2% | 63.0% | ||
| Q1 24 | 5.5% | 63.6% |
营业利润率CLFSYK
| Q4 25 | -7.9% | 25.2% | ||
| Q3 25 | -4.3% | 18.7% | ||
| Q2 25 | -10.1% | 18.5% | ||
| Q1 25 | -11.6% | 14.3% | ||
| Q4 24 | -10.8% | 9.0% | ||
| Q3 24 | -5.7% | 19.7% | ||
| Q2 24 | 0.1% | 19.4% | ||
| Q1 24 | -0.7% | 18.5% |
净利率CLFSYK
| Q4 25 | -5.6% | 11.8% | ||
| Q3 25 | -5.3% | 14.2% | ||
| Q2 25 | -9.5% | 14.7% | ||
| Q1 25 | -10.4% | 11.1% | ||
| Q4 24 | -10.3% | 8.5% | ||
| Q3 24 | -5.3% | 15.2% | ||
| Q2 24 | 0.0% | 15.2% | ||
| Q1 24 | -1.3% | 15.0% |
每股收益（稀释后）CLFSYK
| Q4 25 | — | $2.20 | ||
| Q3 25 | $-0.51 | $2.22 | ||
| Q2 25 | — | $2.29 | ||
| Q1 25 | — | $1.69 | ||
| Q4 24 | $-0.91 | $1.41 | ||
| Q3 24 | $-0.52 | $2.16 | ||
| Q2 24 | $0.00 | $2.14 | ||
| Q1 24 | $-0.14 | $2.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.0M | $4.0B |
| 总债务越低越好 | $7.3B | — |
| 股东权益账面价值 | $6.1B | $22.4B |
| 总资产 | $20.0B | $47.8B |
| 负债/权益比越低杠杆越低 | 1.19× | — |
8季度趋势，按日历期对齐
现金及短期投资CLFSYK
| Q4 25 | $57.0M | $4.0B | ||
| Q3 25 | $66.0M | $3.3B | ||
| Q2 25 | $61.0M | $2.4B | ||
| Q1 25 | $57.0M | $2.3B | ||
| Q4 24 | $54.0M | $3.7B | ||
| Q3 24 | $39.0M | $3.9B | ||
| Q2 24 | $110.0M | $1.9B | ||
| Q1 24 | $30.0M | $2.3B |
总债务CLFSYK
| Q4 25 | $7.3B | — | ||
| Q3 25 | $8.0B | — | ||
| Q2 25 | $7.7B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.1B | — | ||
| Q3 24 | $3.8B | — | ||
| Q2 24 | $3.5B | — | ||
| Q1 24 | $3.7B | — |
股东权益CLFSYK
| Q4 25 | $6.1B | $22.4B | ||
| Q3 25 | $5.5B | $21.8B | ||
| Q2 25 | $5.8B | $21.2B | ||
| Q1 25 | $6.3B | $20.9B | ||
| Q4 24 | $6.7B | $20.6B | ||
| Q3 24 | $6.9B | $20.1B | ||
| Q2 24 | $7.1B | $19.8B | ||
| Q1 24 | $7.2B | $19.2B |
总资产CLFSYK
| Q4 25 | $20.0B | $47.8B | ||
| Q3 25 | $20.3B | $47.1B | ||
| Q2 25 | $20.5B | $46.3B | ||
| Q1 25 | $20.8B | $46.0B | ||
| Q4 24 | $20.9B | $43.0B | ||
| Q3 24 | $16.8B | $43.8B | ||
| Q2 24 | $16.9B | $39.1B | ||
| Q1 24 | $17.2B | $39.4B |
负债/权益比CLFSYK
| Q4 25 | 1.19× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 1.33× | — | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-13.0M | $2.1B |
| 自由现金流经营现金流 - 资本支出 | $-153.0M | $1.9B |
| 自由现金流率自由现金流/营收 | -3.5% | 26.1% |
| 资本支出强度资本支出/营收 | 3.2% | 3.7% |
| 现金转化率经营现金流/净利润 | — | 2.52× |
| 过去12个月自由现金流最近4个季度 | $-1.0B | $4.3B |
8季度趋势，按日历期对齐
经营现金流CLFSYK
| Q4 25 | $-13.0M | $2.1B | ||
| Q3 25 | $-143.0M | $1.5B | ||
| Q2 25 | $45.0M | $1.1B | ||
| Q1 25 | $-351.0M | $250.0M | ||
| Q4 24 | $-472.0M | $1.9B | ||
| Q3 24 | $-84.0M | $1.5B | ||
| Q2 24 | $519.0M | $633.0M | ||
| Q1 24 | $142.0M | $204.0M |
自由现金流CLFSYK
| Q4 25 | $-153.0M | $1.9B | ||
| Q3 25 | $-300.0M | $1.4B | ||
| Q2 25 | $-67.0M | $928.0M | ||
| Q1 25 | $-503.0M | $127.0M | ||
| Q4 24 | $-677.0M | $1.7B | ||
| Q3 24 | $-235.0M | $1.3B | ||
| Q2 24 | $362.0M | $481.0M | ||
| Q1 24 | $-40.0M | $37.0M |
自由现金流率CLFSYK
| Q4 25 | -3.5% | 26.1% | ||
| Q3 25 | -6.3% | 22.3% | ||
| Q2 25 | -1.4% | 15.4% | ||
| Q1 25 | -10.9% | 2.2% | ||
| Q4 24 | -15.7% | 25.9% | ||
| Q3 24 | -5.1% | 23.7% | ||
| Q2 24 | 7.1% | 8.9% | ||
| Q1 24 | -0.8% | 0.7% |
资本支出强度CLFSYK
| Q4 25 | 3.2% | 3.7% | ||
| Q3 25 | 3.3% | 3.1% | ||
| Q2 25 | 2.3% | 3.0% | ||
| Q1 25 | 3.3% | 2.1% | ||
| Q4 24 | 4.7% | 4.1% | ||
| Q3 24 | 3.3% | 3.1% | ||
| Q2 24 | 3.1% | 2.8% | ||
| Q1 24 | 3.5% | 3.2% |
现金转化率CLFSYK
| Q4 25 | — | 2.52× | ||
| Q3 25 | — | 1.79× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | 0.38× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | 259.50× | 0.77× | ||
| Q1 24 | — | 0.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLF
| Hot Rolled Steel | $1.1B | 27% |
| Automotive | $1.1B | 27% |
| Steel Producers | $555.0M | 13% |
| Cold Rolled Steel | $530.0M | 12% |
| Other | $409.0M | 9% |
| Stainless And Electrical Steel | $404.0M | 9% |
| Other Businesses | $159.0M | 4% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
